Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brunner

Showing results (711-720 of 792) with videos related to

Pageof 80
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
A Populus EST resource for plant functional genomicsFredrik Sterky, Rupali R Bhalerao, Per Unneberg, et al.
Annals of Surgical Oncology|October 25, 2019
The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma CohortAndreas A Schnitzbauer, Johannes Eberhard, Fabian Bartsch, et al.
Blood|May 5, 2018
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AMLSanjay S Patel, Frank C Kuo, Christopher J Gibson, et al.
Nature Communications|February 4, 2026
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiationJohannes Griss, Sabina Gansberger, Inigo Oyarzun, et al.
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.
JAMA Oncology|September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of MortalityMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
American Journal of Hematology|October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromesAmer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Blood Advances|July 11, 2020
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophiliaMonica Kasbekar, Valentina Nardi, Paola Dal Cin, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Pageof 80

Showing results (711-720 of 792) with videos related to

Sort By:
Pageof 80
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
A Populus EST resource for plant functional genomicsFredrik Sterky, Rupali R Bhalerao, Per Unneberg, et al.
Annals of Surgical Oncology|October 25, 2019
The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma CohortAndreas A Schnitzbauer, Johannes Eberhard, Fabian Bartsch, et al.
Blood|May 5, 2018
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AMLSanjay S Patel, Frank C Kuo, Christopher J Gibson, et al.
Nature Communications|February 4, 2026
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiationJohannes Griss, Sabina Gansberger, Inigo Oyarzun, et al.
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.
JAMA Oncology|September 8, 2017
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of MortalityMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
American Journal of Hematology|October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromesAmer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Blood Advances|July 11, 2020
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophiliaMonica Kasbekar, Valentina Nardi, Paola Dal Cin, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Pageof 80